GLENMEDE TRUST CO NA - PUMA BIOTECHNOLOGY INC ownership

PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 121 filers reported holding PUMA BIOTECHNOLOGY INC in Q1 2016. The put-call ratio across all filers is 0.64 and the average weighting 0.1%.

Quarter-by-quarter ownership
GLENMEDE TRUST CO NA ownership history of PUMA BIOTECHNOLOGY INC
ValueSharesWeighting
Q3 2020$9,0000.0%9280.0%0.00%
Q2 2020$9,000
-40.0%
928
-47.1%
0.00%
Q1 2020$15,0000.0%1,7540.0%0.00%
Q4 2019$15,000
-16.7%
1,7540.0%0.00%
Q3 2019$18,000
-21.7%
1,754
-5.4%
0.00%
Q2 2019$23,000
-67.6%
1,8540.0%0.00%
Q1 2019$71,000
+91.9%
1,8540.0%0.00%
Q4 2018$37,000
+270.0%
1,854
+984.2%
0.00%
Q2 2018$10,000
-28.6%
171
+17.1%
0.00%
Q1 2018$14,0000.0%1460.0%0.00%
Q4 2017$14,000
+27.3%
146
+46.0%
0.00%
Q3 2017$11,000
+266.7%
1000.0%0.00%
Q2 2017$3,0000.0%1000.0%0.00%
Q1 2017$3,0000.0%1000.0%0.00%
Q4 2016$3,000
-50.0%
1000.0%0.00%
Q3 2016$6,000
+200.0%
1000.0%0.00%
Q2 2016$2,0000.0%1000.0%0.00%
Q1 2016$2,000
-71.4%
1000.0%0.00%
Q4 2015$7,0000.0%1000.0%0.00%
Q3 2015$7,000
-36.4%
1000.0%0.00%
Q2 2015$11,000
-52.2%
1000.0%0.00%
Q1 2015$23,000
+27.8%
1000.0%0.00%
Q4 2014$18,0001000.00%
Other shareholders
PUMA BIOTECHNOLOGY INC shareholders Q1 2016
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 1,300,000$13,338,0002.17%
Camber Capital Management LP 2,555,000$26,214,0000.92%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 3,959,741$40,627,0000.80%
Palo Alto Investors LP 1,373,897$14,096,0000.74%
Sofinnova Investments, Inc. 629,650$6,460,0000.38%
RICE HALL JAMES & ASSOCIATES, LLC 604,937$6,207,0000.22%
J. Goldman & Co LP 238,617$2,448,0000.12%
GLOBEFLEX CAPITAL L P 55,027$565,0000.12%
FRED ALGER MANAGEMENT, LLC 3,416,003$35,048,0000.09%
JUPITER ASSET MANAGEMENT LTD 728,440$7,474,0000.08%
View complete list of PUMA BIOTECHNOLOGY INC shareholders